Vision loss following denileukin diftitox treatment: A case report of possible posterior ischemic optic neuropathy [3]

Leukemia and Lymphoma

Volumn 48, Issue 4, 2007, Pages 808-811

  Park, Meyeon ^a   Liu, Grant T ^b   Piltz Seymour, Jody ^c   Wisda, Catherine L ^d   Rook, Alain H ^b   Junkins Hopkins, Jacqueline M ^b   Nasta, Sunita D ^b   Kim, Ellen J ^b  

^a YALE UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Keystone Eye Associates Subspecialty Center   (United States)

^d Wisda Eye Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BEXAROTENE; BRIMONIDINE; DENILEUKIN DIFTITOX; FUROSEMIDE; RAMIPRIL; TIMOLOL;

AGED; ANAMNESIS; BONE MARROW BIOPSY; CANCER PALLIATIVE THERAPY; CASE REPORT; CLINICAL FEATURE; COLOR BLINDNESS; CUTANEOUS T CELL LYMPHOMA; DRUG WITHDRAWAL; ELECTRON THERAPY; FATIGUE; FEMALE; GONIOSCOPY; HUMAN; HUMAN TISSUE; HYPOTENSION; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; IRIDOTOMY; ISCHEMIC OPTIC NEUROPATHY; LABORATORY TEST; LETTER; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL EDEMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REHYDRATION; SKIN BIOPSY; TREATMENT RESPONSE; VISUAL ACUITY; VISUAL IMPAIRMENT;

AGED; ANTINEOPLASTIC AGENTS; DIPHTHERIA TOXIN; FEMALE; HUMANS; INTERLEUKIN-2; LYMPHOMA, T-CELL; OPTIC NEUROPATHY, ISCHEMIC; RECOMBINANT FUSION PROTEINS; REMISSION INDUCTION; RISK FACTORS; SKIN NEOPLASMS; VISION DISORDERS;

EID: 34247211695     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701268783     Document Type: Letter

References (15)

1. Olsen, E., Duvic, M., Frankel, A., Kim, Y., Martin, A. and Vonderheid, E. (2001) Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma. J Clin Oncol, 19, pp. 376-388.
2. Bacha, P., Williams, D. P., Waters, C., Williams, J. M., Murphy, J. R. and Strom, T. B. (1988) Interleukin-2 receptor-targeted cytotoxicity. J Exp Med, 167, pp. 612-622.
3. Nasu, K., Said, J., Vonderheid, E., Olerud, J., Sako, D. and Kadin, M. (1985) Immunopathology of cutaneous T-cell lymphomas. Am J Pathol, 119, pp. 436-447.
4. Ruddle, J. B., Harper, C. A., Honemann, D., Seymour, J. F. and Prince, H. M. (2006) A denileukin diftitox (Ontak) associated retinopathy?. Br J Ophthalmol, 90, pp. 1070-1071.
5. Willemze, R., Jaffe, E. S., Burg, G., Cerroni, L., Berti, E., Swerdlow, S. H., Ralfkiaer, E. and Chimenti, S. (2005) WHO-EORTC classification for cutaneous lymphomas. Blood, 105, pp. 3768-3785.
6. LeMaistre, C. F., Kuzel, T. M., Saleh, M. N., Platanias, L. C. and Schwartz, G. (1998) Phase I trial of a ligand fusion-protein (DAB389 IL-2) in lymphomas expressing the receptor for interleukin-2. Blood, 91, pp. 399-405.
7. Saleh, M. N., LeMaistre, C. F., Kuzel, T. M., Foss, F., Platanias, L. C. and Schwartz, G. (1998) Antitumor activity of DAB389 IL-2 fusion toxin in mycosis fungoides. J Am Acad Dermatol, 39, pp. 63-73.
8. Roth, S. and Gillesberg, I. (1999) Injuries to the visual system and other sense organs. Anesthesia and Perioperative Complications, pp. 377-408. Mosby, St. Louis, MO
9. Hayreh, S. S., Podhajsky, P. and Zimmerman, M. B. (1999) Role of nocturnal arterial hypotension in optic nerve head ischemic disorders. Ophthalmologica, 213, pp. 76-96.
10. Sadda, S. R., Nee, M., Miller, N. R., Biousse, V., Newman, N. J. and Kouzis, A. (2001) Clinical spectrum of posterior ischemic optic neuropathy. Am J Ophthal, 132, pp. 743-750.
11. Chang, S. H. and Miller, N. R. (2005) The incidence of vision loss due to perioperative ischemic optic neuropathy associated with spine surgery. Spine, 30, pp. 1299-1302.
12. Remigio, D. and Wertenbaker, C. (2000) Post-operative bilateral vision loss. Surv Opthalmol, 44, pp. 426-432.
13. Buono, L. M. and Foroozan, R. (2005) Perioperative posterior ischemic optic neuropathy: Review of the literature. Surv Ophthalmol, 50, pp. 15-26.
14. Isayama, Y., Takahashi, T., Inoue, M. and Jimura, T. (1983) Posterior ischemic optic neuropathy. III. Clinical diagnosis. Ophthalmologica, 187, pp. 141-147.
15. Lee, A. G. (1995) Reversible loss of vision due to posterior ischemic optic neuropathy. Can J Ophthalmol, 30, pp. 327-329.